Bleeding Associated With Feeding Tube Placement in Critically Ill Oncology Patients With Thrombocytopenia

Patel, Rina P.; Canada, Todd W.; Nates, Joseph L.

doi:10.1177/0884533615598964

Cited by 11 publications

(20 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…No difference was seen between the groups in any of the secondary objectives. Of note, more patients with thrombocytopenia received blood transfusions 24 hours prior to feeding tube placement than those without thrombocytopenia (86% vs 12%, P < .001) 82 …”

Section: Feeding Tube Placement In Patients With Thrombocytopeniamentioning

confidence: 99%

“…Since this complication is common among critically ill patients with cancer, it is important to evaluate the risk and benefit of feeding tube placement in this population. To date, only 1 study has evaluated the feasibility of feeding tube placement in thrombocytopenic critically ill patients with cancer 82 …”

Section: Feeding Tube Placement In Patients With Thrombocytopeniamentioning

confidence: 99%

“…The primary objective was to compare the incidence of overt and clinically important bleeding complications within 72 hours of attempted feeding tube placement. Secondary objectives of the study were number of attempts for feeding tube placement, number of aborted feeding tube placements, number of displaced feeding tubes requiring replacement or adjustment, number of blood transfusions required within 72 hours of feeding tube placement, and number of patients to reach goal EN by ICU day 7 or discharge 82 . There were no differences in overt and clinically important bleeding complications between those with and without thrombocytopenia, within 72 hours of feeding tube placement 82 .…”

Section: Feeding Tube Placement In Patients With Thrombocytopeniamentioning

confidence: 99%

“…Patel et al 82 completed a study in a medical ICU to investigate bleeding complications after feeding tube placement in critically ill oncology patients with or without thrombocytopenia (defined as a platelet count <150,000/µL). The primary objective was to compare the incidence of overt and clinically important bleeding complications within 72 hours of attempted feeding tube placement.…”

Section: Feeding Tube Placement In Patients With Thrombocytopeniamentioning

confidence: 99%

“…Patel et al concluded that critically ill patients with cancer and thrombocytopenia are not at increased risk for bleeding complications after feeding tube placement than those without thrombocytopenia, although this could likely be due to blood transfusions occurring within 24 hours prior to feeding tube placement 82 . Larger prospective studies are needed to make definitive conclusions regarding risk of bleeding with feeding tube placement in patients with thrombocytopenia.…”

Section: Feeding Tube Placement In Patients With Thrombocytopeniamentioning

confidence: 99%

See 4 more Smart Citations

Nutrition Support for Critically Ill Patients With Cancer

Lach

Peterson

2017

Nut in Clin Prac

View full text Add to dashboard Cite

Oncology patients often experience the classic signs of malnutrition-weight loss as well as fat and muscle wasting, which have been associated with poor tolerance to treatment and increased morbidity and mortality. Nutrition status may be an important factor in determining tolerance to treatment and outcomes associated with it. Thus, identification of those with preexisting malnutrition or who are at risk for developing malnutrition is crucial not only at time of cancer diagnosis but also throughout the treatment course so that nutrition interventions may be implemented to prevent development or worsening of malnutrition in this high-risk population. These patients often have extremely complicated hospital courses due to the aggressive nature of the disease and treatment, leading to intensive care unit admission and periods of critical illness. Critical illness is associated with catabolism, extreme stress on the body, and a state of systemic inflammation. During critical illness, it is important to provide adequate nutrition to prevent further break down of lean muscle mass and oxidative cellular injury and to regulate favorable immune responses. The purpose of this review is to discuss the importance of nutrition screening and assessment for the critically ill patient with cancer; to appropriately identify those at risk for, or who have developed, malnutrition; and to provide appropriate interventions to optimize nutrition status. This review also discusses the complications and difficulties associated with feeding this patient population and offers nutrition support recommendations.

show abstract

Section: Feeding Tube Placement In Patients With Thrombocytopeniamentioning

confidence: 99%

Section: Feeding Tube Placement In Patients With Thrombocytopeniamentioning

confidence: 99%

Section: Feeding Tube Placement In Patients With Thrombocytopeniamentioning

confidence: 99%

Section: Feeding Tube Placement In Patients With Thrombocytopeniamentioning

confidence: 99%

Section: Feeding Tube Placement In Patients With Thrombocytopeniamentioning

confidence: 99%

See 3 more Smart Citations

Nutrition Support for Critically Ill Patients With Cancer

Lach

Peterson

2017

Nut in Clin Prac

View full text Add to dashboard Cite

show abstract

Considerations for medical nutrition therapy management of the critically ill patient with hematological malignancies: A narrative review

Lopez‐Delgado,

Patel,

Stoppe

et al. 2024

Nut in Clin Prac

View full text Add to dashboard Cite

Patients with hematological malignancies (HMs) are more frequently admitted now than in the past to the intensive care unit (ICU) due to more aggressive approaches in primary therapy of HMs and the need for critical care support. Pathophysiological alterations derived from HMs and the different hematological therapies, such as chemotherapy, negatively affect gastrointestinal (GI) function, metabolism, and nutrition status. Further, malnutrition strongly influences outcomes and tolerance of the different hematological therapies. In consequence, these critically ill patients frequently present with malnutrition and pathophysiological alterations that create challenges for the delivery of medical nutrition therapy (MNT) in the ICU. Frequent screening, gauging tolerance, and monitoring nutrition status are mandatory to provide individualized MNT and achieve nutrition objectives. The present review discusses how HM impact GI function and nutrition status, the importance of MNT in patients with HM, and specific considerations for guidance in providing adequate MNT to these patients when admitted to the ICU.

show abstract